OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A synergistic role of convalescent plasma and mesenchymal stem cells in the treatment of severely ill COVID-19 patients: a clinical case report
Hongbing Peng, Tiefeng Gong, Xiaoying Huang, et al.
Stem Cell Research & Therapy (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 62
Hongbing Peng, Tiefeng Gong, Xiaoying Huang, et al.
Stem Cell Research & Therapy (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 62
Showing 1-25 of 62 citing articles:
Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review
Vanessa Piechotta, Khai Li Chai, Sarah J Valk, et al.
Cochrane library (2020)
Open Access | Times Cited: 327
Vanessa Piechotta, Khai Li Chai, Sarah J Valk, et al.
Cochrane library (2020)
Open Access | Times Cited: 327
Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review
Vanessa Piechotta, Claire Iannizzi, Khai Li Chai, et al.
Cochrane library (2021) Vol. 2021, Iss. 5
Open Access | Times Cited: 188
Vanessa Piechotta, Claire Iannizzi, Khai Li Chai, et al.
Cochrane library (2021) Vol. 2021, Iss. 5
Open Access | Times Cited: 188
Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review
Khai Li Chai, Sarah J Valk, Vanessa Piechotta, et al.
Cochrane library (2020)
Open Access | Times Cited: 138
Khai Li Chai, Sarah J Valk, Vanessa Piechotta, et al.
Cochrane library (2020)
Open Access | Times Cited: 138
Evaluation of the safety and efficacy of using human menstrual blood‐derived mesenchymal stromal cells in treating severe and critically ill COVID‐19 patients: An exploratory clinical trial
Xiaowei Xu, Wanli Jiang, Lijun Chen, et al.
Clinical and Translational Medicine (2021) Vol. 11, Iss. 2
Open Access | Times Cited: 112
Xiaowei Xu, Wanli Jiang, Lijun Chen, et al.
Clinical and Translational Medicine (2021) Vol. 11, Iss. 2
Open Access | Times Cited: 112
Evidence favouring the efficacy of convalescent plasma for COVID-19 therapy
Michael J. Joyner, Stephen A. Klassen, Jonathon W. Senefeld, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 89
Michael J. Joyner, Stephen A. Klassen, Jonathon W. Senefeld, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 89
Mesenchymal stem cell therapy for severe COVID-19
Lei Shi, Lifeng Wang, Ruonan Xu, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 86
Lei Shi, Lifeng Wang, Ruonan Xu, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 86
Human mesenchymal stem cells treatment for severe COVID-19: 1-year follow-up results of a randomized, double-blind, placebo-controlled trial
Lei Shi, Xin Yuan, Weiqi Yao, et al.
EBioMedicine (2021) Vol. 75, pp. 103789-103789
Open Access | Times Cited: 86
Lei Shi, Xin Yuan, Weiqi Yao, et al.
EBioMedicine (2021) Vol. 75, pp. 103789-103789
Open Access | Times Cited: 86
Mesenchymal stem cell treatment for COVID-19
Ruonan Xu, Zhiqian Feng, Fu‐Sheng Wang
EBioMedicine (2022) Vol. 77, pp. 103920-103920
Open Access | Times Cited: 57
Ruonan Xu, Zhiqian Feng, Fu‐Sheng Wang
EBioMedicine (2022) Vol. 77, pp. 103920-103920
Open Access | Times Cited: 57
Mesenchymal stromal cell therapy for COVID-19-induced ARDS patients: a successful phase 1, control-placebo group, clinical trial
Najmeh Kaffash Farkhad, Alireza Sedaghat, Hamidreza Reihani, et al.
Stem Cell Research & Therapy (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 47
Najmeh Kaffash Farkhad, Alireza Sedaghat, Hamidreza Reihani, et al.
Stem Cell Research & Therapy (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 47
SARS-CoV-2 Infection and Lung Regeneration
Fuxiaonan Zhao, Qingwen Ma, Qing Yue, et al.
Clinical Microbiology Reviews (2022) Vol. 35, Iss. 2
Open Access | Times Cited: 43
Fuxiaonan Zhao, Qingwen Ma, Qing Yue, et al.
Clinical Microbiology Reviews (2022) Vol. 35, Iss. 2
Open Access | Times Cited: 43
Convalescent plasma for people with COVID-19: a living systematic review
Claire Iannizzi, Khai Li Chai, Vanessa Piechotta, et al.
Cochrane library (2023) Vol. 2023, Iss. 2
Open Access | Times Cited: 31
Claire Iannizzi, Khai Li Chai, Vanessa Piechotta, et al.
Cochrane library (2023) Vol. 2023, Iss. 2
Open Access | Times Cited: 31
Convalescent plasma for people with COVID-19: a living systematic review
Claire Iannizzi, Khai Li Chai, Vanessa Piechotta, et al.
Cochrane library (2023) Vol. 2024, Iss. 2
Closed Access | Times Cited: 31
Claire Iannizzi, Khai Li Chai, Vanessa Piechotta, et al.
Cochrane library (2023) Vol. 2024, Iss. 2
Closed Access | Times Cited: 31
Convalescent plasma may be a possible treatment for COVID-19: A systematic review
Ying Wang, Pengfei Huo, Rulin Dai, et al.
International Immunopharmacology (2020) Vol. 91, pp. 107262-107262
Open Access | Times Cited: 56
Ying Wang, Pengfei Huo, Rulin Dai, et al.
International Immunopharmacology (2020) Vol. 91, pp. 107262-107262
Open Access | Times Cited: 56
Mesenchymal stem cells: Biological characteristics and application in disease therapy
Songyue Lou, Yongtao Duan, Huizong Nie, et al.
Biochimie (2021) Vol. 185, pp. 9-21
Closed Access | Times Cited: 48
Songyue Lou, Yongtao Duan, Huizong Nie, et al.
Biochimie (2021) Vol. 185, pp. 9-21
Closed Access | Times Cited: 48
Spotlight on therapeutic efficiency of mesenchymal stem cells in viral infections with a focus on COVID-19
Saman Yasamineh, Hesam Ghafouri Kalajahi, Pooneh Yasamineh, et al.
Stem Cell Research & Therapy (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 37
Saman Yasamineh, Hesam Ghafouri Kalajahi, Pooneh Yasamineh, et al.
Stem Cell Research & Therapy (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 37
Mesenchymal stem cell-based treatments for COVID-19: status and future perspectives for clinical applications
Lijun Chen, Jingjing Qu, Farhin Shaheed Kalyani, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 3
Open Access | Times Cited: 33
Lijun Chen, Jingjing Qu, Farhin Shaheed Kalyani, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 3
Open Access | Times Cited: 33
Rescuing emergency cases of COVID-19 patients: An intelligent real-time MSC transfusion framework based on multicriteria decision-making methods
M. A. Alsalem, O. S. Albahri, A. A. Zaidan, et al.
Applied Intelligence (2022) Vol. 52, Iss. 9, pp. 9676-9700
Open Access | Times Cited: 25
M. A. Alsalem, O. S. Albahri, A. A. Zaidan, et al.
Applied Intelligence (2022) Vol. 52, Iss. 9, pp. 9676-9700
Open Access | Times Cited: 25
Mesenchymal stem/stromal cell therapy for COVID-19 pneumonia: potential mechanisms, current clinical evidence, and future perspectives
Weiqi Yao, Lei Shi, Yun Zhang, et al.
Stem Cell Research & Therapy (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 23
Weiqi Yao, Lei Shi, Yun Zhang, et al.
Stem Cell Research & Therapy (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 23
The Role of MSC Therapy in Attenuating the Damaging Effects of the Cytokine Storm Induced by COVID-19 on the Heart and Cardiovascular System
Georgina M. Ellison, Liam Colley, Katie A. O’Brien, et al.
Frontiers in Cardiovascular Medicine (2020) Vol. 7
Open Access | Times Cited: 33
Georgina M. Ellison, Liam Colley, Katie A. O’Brien, et al.
Frontiers in Cardiovascular Medicine (2020) Vol. 7
Open Access | Times Cited: 33
Current utilization of interferon alpha for the treatment of coronavirus disease 2019: A comprehensive review
Ling‐Ying Lu, Po‐Hao Feng, Ming‐Sun Yu, et al.
Cytokine & Growth Factor Reviews (2022) Vol. 63, pp. 34-43
Open Access | Times Cited: 20
Ling‐Ying Lu, Po‐Hao Feng, Ming‐Sun Yu, et al.
Cytokine & Growth Factor Reviews (2022) Vol. 63, pp. 34-43
Open Access | Times Cited: 20
Therapeutic mechanisms of mesenchymal stem cells in acute respiratory distress syndrome reveal potentials for Covid-19 treatment
Wendi Wang, Wei Lei, Lina Jiang, et al.
Journal of Translational Medicine (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 25
Wendi Wang, Wei Lei, Lina Jiang, et al.
Journal of Translational Medicine (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 25
Review of the potential of mesenchymal stem cells for the treatment of infectious diseases
Amit Sharma, Anuja Chakraborty, Bithiah Grace Jaganathan
World Journal of Stem Cells (2021) Vol. 13, Iss. 6, pp. 568-593
Open Access | Times Cited: 25
Amit Sharma, Anuja Chakraborty, Bithiah Grace Jaganathan
World Journal of Stem Cells (2021) Vol. 13, Iss. 6, pp. 568-593
Open Access | Times Cited: 25
When stem cells meet COVID-19: recent advances, challenges and future perspectives
Shasha Li, Hecheng Zhu, Ming Zhao, et al.
Stem Cell Research & Therapy (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 18
Shasha Li, Hecheng Zhu, Ming Zhao, et al.
Stem Cell Research & Therapy (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 18
Efficacy and Safety of MSC Cell Therapies for Hospitalized Patients with COVID-19: A Systematic Review and Meta-Analysis
Wenchun Qu, Zhen Wang, Erica Engelberg-Cook, et al.
Stem Cells Translational Medicine (2022) Vol. 11, Iss. 7, pp. 688-703
Open Access | Times Cited: 16
Wenchun Qu, Zhen Wang, Erica Engelberg-Cook, et al.
Stem Cells Translational Medicine (2022) Vol. 11, Iss. 7, pp. 688-703
Open Access | Times Cited: 16
Stem cell therapy in COVID-19: Pooled evidence from SARS-CoV-2, SARS-CoV, MERS-CoV and ARDS: A systematic review
Saniya Mahendiratta, Seema Bansal, Phulen Sarma, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 137, pp. 111300-111300
Open Access | Times Cited: 23
Saniya Mahendiratta, Seema Bansal, Phulen Sarma, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 137, pp. 111300-111300
Open Access | Times Cited: 23
